310947160	310947160	CD	B-NP	O
|	|	NN	I-NP	O
VCGH	VCGH	NN	I-NP	O
|	|	NN	I-NP	O
61430183	61430183	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
022171	022171	CD	B-NP	O
|	|	CC	I-NP	O
7/19/2002	7/19/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/16/2002	7/16/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/1/2002	9/1/2002	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
EXACERBATION	EXACERBATION	NNP	I-NP	O
.	.	.	O	O

PROBLEMS	PROBLEMS	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CHRONIC	CHRONIC	NN	B-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
AN	AN	NN	I-NP	O
EJECTION	EJECTION	NN	I-NP	O
FRACTION	FRACTION	NN	I-NP	O
OF	OF	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
2-VESSEL	2-VESSEL	NN	I-NP	O
CABG	CABG	NN	I-NP	O
IN	IN	IN	B-PP	O
June	June	NNP	B-NP	O
2001	2001	CD	I-NP	O
,	,	,	O	O
STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
IN	IN	IN	B-PP	O
June	June	NNP	B-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	VBZ	B-VP	O
X10	X10	NN	B-NP	B-protein
YEARS	YEARS	NNS	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

PERIPHEROVASCULAR	PERIPHEROVASCULAR	NN	B-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
BLADDER	BLADDER	NN	B-NP	O
CANCER	CANCER	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
RESECTION	RESECTION	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

LUMBAR	LUMBAR	NN	B-NP	O
STENOSIS	STENOSIS	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
,	,	,	O	O
BASELINE	BASELINE	NNP	B-NP	O
CREATININE	CREATININE	NNP	I-NP	O
1.1-1	1.1-1	CD	I-NP	O
.4	.4	CD	I-NP	O
.	.	.	O	O

OPERATIONS/PROCEDURES	OPERATIONS/PROCEDURES	NNP	B-NP	O
:	:	:	O	O
Intubation	Intubation	NN	B-NP	O
and	and	CC	I-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
79-year-old	79-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
admits	admit	VBZ	B-VP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretion	indiscretion	NN	I-NP	O
,	,	,	O	O
having	have	VBG	B-VP	O
been	be	VBN	I-VP	O
eating	eat	VBG	I-VP	O
Chinese	Chinese	JJ	B-NP	O
food	food	NN	I-NP	O
but	but	CC	O	O
reports	report	VBZ	B-VP	O
good	good	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
her	her	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
gain	gain	NN	I-NP	O
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
going	go	VBG	B-VP	O
from	from	IN	B-PP	O
184	184	CD	B-NP	O
to	to	TO	I-NP	O
186	186	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
severe	severe	JJ	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
considerable	considerable	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
listed	list	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
42	42	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
and	and	CC	O	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
cozor	cozor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
next	next	JJ	B-NP	O
door	door	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Quit	Quit	NNP	B-NP	O
smoking	smoke	VBG	B-VP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
123/72	123/72	CD	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
ear	ear	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
one-third	one-third	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
scattered	scatter	VBN	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Irregularly	Irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
reported	report	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
diamond	diamond	NN	I-NP	O
shaped	shape	VBD	B-VP	O
early	early	RB	I-VP	O
peaking	peak	VBG	I-VP	O
systolic	systolic	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
stenosis/sclerosis	stenosis/sclerosis	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

Left	Leave	VBN	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	NN	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ankles	ankle	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Chemistries	Chemistry	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
34	34	CD	I-NP	I-DNA
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
48.1	48.1	CD	I-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
at	at	IN	B-PP	O
33	33	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.02	0.02	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
April	April	NNP	B-NP	O
2001	2001	CD	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
On	On	IN	B-PP	O
2/6/02	2/6/02	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
20s	20	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
presyncopal	presyncopal	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
code	code	NN	I-NP	O
blue	blue	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
atropine	atropine	NN	B-NP	O
and	and	CC	I-NP	O
transthoracic	transthoracic	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
and	and	CC	I-NP	O
Dopamine	Dopamine	NN	I-NP	O
for	for	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
weaned	wean	VBD	B-VP	O
slowly	slowly	RB	B-ADVP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
vent	vent	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	B-DNA
care	care	NN	I-NP	I-DNA
unit	unit	NN	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
3/20/02	3/20/02	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
convalescing	convalesce	VBG	I-VP	O
,	,	,	O	O
diuresing	diurese	VBG	B-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
500-1	500-1	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
cc	cc	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
IV	IV	CD	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Captopril	Captopril	NNP	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	I-VP	O
zestril	zestril	VB	I-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
48	48	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
relative	relative	JJ	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
if	if	IN	B-SBAR	O
this	this	DT	B-NP	O
persists	persist	VBZ	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
fever	fever	NN	B-NP	O
and	and	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O

Sputum	Sputum	NNP	B-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
grew	grow	VBD	B-VP	O
pansensitive	pansensitive	JJ	B-NP	O
pneumococcus	pneumococcus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	I-VP	O
amoxicillin	amoxicillin	VB	I-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
seven	seven	CD	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
temporarily	temporarily	RB	B-ADVP	O
on	on	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
nebs	neb	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
11/28/02	11/28/02	CD	B-NP	O
.	.	.	O	O

FEN/GI	FEN/GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
hypernatremia	hypernatremia	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
152	152	CD	B-NP	O
and	and	CC	O	O
contraction	contraction	NN	B-NP	O
on	on	IN	B-PP	O
glyc	glyc	NN	B-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
correcting	correct	VBG	B-VP	O
her	her	PRP$	B-NP	O
intravascular	intravascular	JJ	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
lytes	lyte	NNS	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
regular	regular	JJ	B-NP	O
NPH	NPH	NN	I-NP	O
doses	dose	NNS	I-NP	O
with	with	IN	B-PP	O
CZI	CZI	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	I-protein
scale	scale	NN	B-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
Although	Although	IN	B-SBAR	I-protein
morning	morning	NN	B-NP	I-protein
sugars	sugar	NNS	I-NP	I-protein
ranged	range	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60-70s	60-70	NNS	I-NP	O
,	,	,	O	O
afternoon	afternoon	NN	B-NP	O
glucoses	glucose	NNS	I-NP	O
were	be	VBD	B-VP	O
often	often	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Acevedo	Acevedo	NNP	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
may	may	MD	B-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
consider	consider	VB	I-VP	O
adding	add	VBG	I-VP	O
a	a	DT	B-NP	O
midday	midday	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

DERMATOLOGY	DERMATOLOGY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
palmar	palmar	NN	B-NP	O
and	and	CC	I-NP	O
plantar	plantar	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
by	by	IN	B-PP	O
dermatology	dermatology	NN	B-NP	O
as	as	IN	B-PP	O
palmoplantar	palmoplantar	JJ	B-NP	O
keratoderma	keratoderma	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
miconazole	miconazole	NN	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
gave	give	VBD	B-VP	O
recommendations	recommendation	NNS	B-NP	O
about	about	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
use	use	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
and	and	CC	I-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
and	and	CC	O	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
MHAC	MHAC	NN	I-NP	O
care	care	NN	I-NP	O
coordination	coordination	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	O
875	875	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
x6	x6	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
buffered	buffer	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
42	42	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
zestril	zestril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
cozor	cozor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Sunday	Sunday	NNP	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
BRIAN	BRIAN	NN	B-NP	O
A.	A.	NN	I-NP	O
MONGEAU	MONGEAU	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LK80	LK80	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOWELL	LOWELL	NNP	B-NP	O
L.	L.	NNP	I-NP	O
GUNDRY	GUNDRY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
KV2	KV2	NNP	I-NP	O
HO160/452383	HO160/452383	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
24331	24331	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

R2NYGI7HY5	R2NYGI7HY5	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
6/20/02	6/20/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/20/02	6/20/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

NAPOLEON	NAPOLEON	NNP	B-NP	O
BRZOZOWSKI	BRZOZOWSKI	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

